Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, featuring promising breakthroughs across numerous clinical and industrial purposes. With its structural similarity to The natural way derived human serum albumin, OsrHSA delivers a safer, a lot more reliable alternative for therapeutic use